About Advanced Accelerator Applications Canada Inc.
Advanced Accelerator Applications Canada Inc., a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine.
Advanced Accelerator Applications currently has over 1,000 employees working across 29 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries.
For more information, please visit: https://www.adacap.com.